The FDA approved Y-90 resin microspheres for the treatment of unresectable hepatocellular carcinoma, according to a press ...

"BioAtla presents Phase I data of BA3182 for metastatic adenocarcinoma" was originally created and published by Clinical ...

HIV-infected patients in this study were diagnosed and treated for colon adenocarcinoma and tended to have specific clinical and pathological characteristics. How should screening change?

Colorectal adenocarcinoma incidence is decreasing overall but increasing among individuals aged 15 to 34 years, with an APC of 1.75. Pancreatic adenocarcinoma incidence is rising across all age ...

Sirtex Medical ("Sirtex"), a leading manufacturer of interventional oncology solutions, today announced that the U.S. Food ...

Research presented at the ASCO Annual Meeting 2025 highlighted potential new standards of care and other advances in ...

About The Study: The findings of this cohort study suggest that the incidence of pancreatic adenocarcinoma has increased among all age groups, whereas that of colorectal adenocarcinoma has ...

Pancreatic adenocarcinoma incidence increased among all age groups. Most cases occurred among patients aged 55 years and older (n = 239,840), followed by those aged 35 to 54 years (n = 33,800) and ...

The APC for colorectal adenocarcinoma was −3.31% for those aged 55 years and older, which was significantly lower than the APCs of 1.75% and 0.78% for those aged 15 to 34 and 35 to 54 years, ...

Sirtex Medical’s SIR-Spheres Y-90 resin microspheres receive US FDA nod to treat unresectable hepatocellular carcinoma: Woburn, Massachusetts Tuesday, July 8, 2025, 17:00 Hrs [I ...